Dr. David Samadi Revolutionizes Prostate Surgery The “SMART” Way

The story has been told thousands of times, poor immigrant arrives in USA, works hard, studies hard and finds success and as cliche as it may sound in the beginning, these stories never get old. This similar story is no exception and certainly not if you are one of the thousands of lives that have been saved because of this successful individuals accomplishments.

Dr. David Samadi is a now famous urologist who’s practice specializes in diagnosing and treating urological disease, prostate, kidney and bladder cancer with pioneering and unique least invasive techniques that have been revolutionary against the battle of these terrible diseases. Revolution is nothing new to Dr. David Samadi as he was born in Iran and raised in a Persian Jewish community that he was forced to flee with his brother at the age of 15 following the Iranian Revolution.

The two young teenagers fled to Belgium and were separated from their family leaving them on their own. Eventually they found their way to America where David began his educational pursuit to become a doctor. His journey through medical education saw him through successful completion at Stony Brook University, Stony Brook School of Medicine, Montefiore Medical Center and Albert Einstein College.

During his tenure of medical practice in the fields of Urology and Proctology, Dr. David Samadi has many major accomplishments, awards and recognitions but one that stands out in particular is his work and development of what is known as “SMART” surgery for urinary continence and sex after prostate cancer.

The SMART technique for prostate cancer has become very popular around the world. The technique reverses the way a normal prostate operation is performed. Instead of removing the nerves and mobilizing them away from the prostate he removes the prostate away from the nerves so that they nerves are not touched in the procedure, so the continence and sexual function are not effected.

Dr. David Samadi explains that it is not just what you remove when performing prostate surgery, the cancer, but also just as important is what you leave behind, in this case the nerves that control continence and sexual functions. This work has brought awareness to the fact that not just men are affected by prostate cancer but wives and girlfriends are as well because of the sexual dysfunction that was a result of old prostate removal techniques prior to his revolutionary SMART techniques that are changing the way surgeons approach prostate cancer.

Learn More: www.roboticoncology.com/

Clay Siegall Further Injects Supports To Find Solutions To Cancer Treatment

 

Clay Siegall is one of the clinical experts who have heavily invested their time and energy to cancer research and the development of options of treatment that are focused on reducing and eliminating the ravages of the disease. Over the past one decade, many companies have ventured into this industry and have helped to reveal vital details about the disease. Coupled with modern technology, the ideas raised through research have led to the development of innovative ways of treating cancer. Seattle Genetics, which was founded by Clay Siegall, has been on the forefront offering new technologies and drug pipelines that are focused on supporting the treatment of cancer.

Since inception, Seattle Genetics has maintained focus on developing cancer solutions. Although the company also makes other types of drugs, its investment in cancer research has been intense over the past 10 years. Clay Siegall describes this shift as a result of the great support they have been receiving from the industry. His team has been working on the ADC Technology, which was tested and proved to work seamlessly while treating cancer. One uniqueness about the ADC Technology is that it treats cancer by focusing only on the harmful cells while ignoring healthy cells. This assures the patient of a solution that will not interfere with other parts of the body.

More about Clay Siegall

Clay Siegall has been serving as a clinical scientist for over three decades and his influence in the cancer research industry saw the birth of Seattle Genetics, a company that has been delivering solutions for many years. Through the company, he has championed research to introduce new technologies and products aimed at supporting cancer treatment.

One of the products that were introduced through the company is ADCETRIS, a drug pipeline that has seen high rates of adoption and approval across many countries. The ADC Technology is also a milestone that allowed Seattle Genetics to get partnerships and new members to support the company in the cancer research programs. Clay Siegall is an accomplished clinical scientist and he founded Seattle Genetics on the idea of research and innovation of ideas to deliver solutions for cancer treatment.